Retinal Oxygen Metabolism in Children With Myopia
Key facts
- Who runs it
- Medical University of Vienna
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Started
- 11 May 2026
- Expected to end
- 2 Jan 2027
- Type of study
- Observational, 2 groups
- Record updated
- 16 March 2026
Who can take part
- Age
- 8 years to 13 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Children aged between 8 and 13 years (inclusive)
- Signed informed consent of child and legal guardian
- Normal ophthalmic findings except myopia
- Cycloplegic spherical equivalent (SE) refraction ≤ -1.0dpt in both eyes
- Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
- Children aged between 8 and 13 years (inclusive)
- Signed informed consent of child and legal guardian
- Normal ophthalmic findings
- Cycloplegic spherical equivalent (SE) refraction between +0.5dpt and -0.5dpt
- Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
Who cannot take part
- Previous eye abnormalities such as cataract, keratopathy, strabismus, amblyopia, ocular inflammation, trauma, or surgery
- History of any disease or syndrome associated with severe myopia such as Marfan syndrome, Stickler syndrome, or retinopathy of prematurity
- Intake of stimulating beverages containing xanthine derivatives (tea, coffee, cola-like drinks) 12 hours before the study day
- Non-axial cause of myopia
- BCVA less than 20/25
- Intraocular pressure ≥ 21mmHg
- Astigmatism ≤ -1.0dpt
- Anisometropia ≥ 2dpt
- Not able to read letters for visual acuity testing
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 8 and 13 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the present study is to gain more information about retinal functional parameters in myopic children in Europe. For this purpose, a prospective case-control study in children aged between 8 and 13 years, as this is the usual age of myopia onset, will be conducted. Forty myopic children will be age- and sex-matched to non-myopic controls. Retinal oxygen extraction will be used as the main outcome parameter, as data from animal and human studies point towards an involvement of hypoxia in the disease process. In addition, other parameters probably linked to myopia will be investigated, such as retinal and choroidal blood flow as well as choroidal and retinal vessel density and anatomical structures such as choroidal and central retinal thickness. Also, questionnaires about lifestyle factors will be completed.
The 2 groups in the trial
- children with myopia
- healthy age- and sex-matched controls
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07473401, who can take part
- Record updated
- 16 March 2026